- Home
- GLOB vs ASND Comparison
GLOB vs ASND Comparison
Compare GLOB & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLOB
- ASND
- Stock Information
- Founded
- GLOB 2003
- ASND 2006
- Country
- GLOB Luxembourg
- ASND Denmark
- Employees
- GLOB N/A
- ASND N/A
- Industry
- GLOB EDP Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- GLOB Technology
- ASND Health Care
- Exchange
- GLOB Nasdaq
- ASND Nasdaq
- Market Cap
- GLOB 8.7B
- ASND 7.7B
- IPO Year
- GLOB 2014
- ASND 2015
- Fundamental
- Price
- GLOB $215.44
- ASND $123.00
- Analyst Decision
- GLOB Buy
- ASND Strong Buy
- Analyst Count
- GLOB 19
- ASND 13
- Target Price
- GLOB $228.42
- ASND $195.92
- AVG Volume (30 Days)
- GLOB 453.5K
- ASND 391.4K
- Earning Date
- GLOB 11-14-2024
- ASND 11-05-2024
- Dividend Yield
- GLOB N/A
- ASND N/A
- EPS Growth
- GLOB 10.97
- ASND N/A
- EPS
- GLOB 3.83
- ASND N/A
- Revenue
- GLOB $2,284,526,000.00
- ASND $340,327,869.00
- Revenue This Year
- GLOB $17.51
- ASND $16.12
- Revenue Next Year
- GLOB $15.59
- ASND $87.44
- P/E Ratio
- GLOB $57.16
- ASND N/A
- Revenue Growth
- GLOB 19.01
- ASND 166.54
- 52 Week Low
- GLOB $151.68
- ASND $86.55
- 52 Week High
- GLOB $251.50
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- GLOB 60.94
- ASND 39.09
- Support Level
- GLOB $215.50
- ASND $124.02
- Resistance Level
- GLOB $224.47
- ASND $133.97
- Average True Range (ATR)
- GLOB 5.23
- ASND 3.67
- MACD
- GLOB -0.04
- ASND -0.33
- Stochastic Oscillator
- GLOB 65.65
- ASND 15.18
About GLOB Globant S.A.
Globant SA is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the U.S. and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.